Skip to Content
 

VICC toll-free number 1-877-936-8422

Endocrine Cancers

Clinical Trials for Endocrine Cancers

2 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Treatment

COGADVL1522

08/02/2016

A Phase 2 Study of IMGN901 (Lorvotuzumab Mertansine; IND# 126953, NSC# 783609) in Children with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) and Synovial Sarcoma

Treatment

VICCMD15110

04/05/2016

A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors